Regal Investment Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Regal Investment Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-185	Closed	-$5K	–	757
2015 Q3	$5K	Buy	+185	New	+$6.46K	﹤0.01%	812

Other funds holding SBIO

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Regal Investment Advisors's SBIO Position: Q4 2015 in Review

Regal Investment Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2015, closing a stake of 185 shares — an estimated $5K sold.

Regal Investment Advisors first reported a position in SBIO in Q3 2015 and held it in 1 quarter. The position peaked at $5K in Q3 2015. 31 funds tracked by Wall St. Rank hold SBIO as of Q4 2015.

Regal Investment Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2015 after selling out during the quarter.
Regal Investment Advisors sold 185 ALPS Medical Breakthroughs ETF shares in Q4 2015, an estimated $5K.
Regal Investment Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q3 2015 and held it in 1 quarter.
Regal Investment Advisors's ALPS Medical Breakthroughs ETF position peaked at $5K in Q3 2015.
31 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2015.

Based on Regal Investment Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.